Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.04 USD | +3.75% | +44.76% | -33.91% |
05-06 | NRx Pharmaceuticals Shares Rise 38% After Positive Drug Trial Data | DJ |
05-06 | NRx Pharmaceuticals, Inc. Announces Final Clinical Trial Results | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-33.91% | 31.68M | |
+17.96% | 44.96B | |
+1.17% | 42.65B | |
+48.77% | 41.85B | |
-4.27% | 29.04B | |
+11.42% | 26.08B | |
-21.39% | 19.03B | |
+4.86% | 12.75B | |
+27.29% | 12.06B | |
-3.50% | 11.75B |
- Stock Market
- Equities
- BRPA Stock
- News NRx Pharmaceuticals, Inc.
- Transcript : NRx Pharmaceuticals, Inc., Q3 2023 Earnings Call, Nov 14, 2023